Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | PRKDC | P78527 | 3/20 | 0.41 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.32 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.32 |
| ▸ | TNKS | O95271 | 1/20 | 0.32 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.31 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15959774 | 1.00 | ALOX5 (0.46) | ALOX5PRKDCPARP14DNPH1TNKS | |
| SCHEMBL17248448 | 0.89 | ALOX5 (0.48) | ALOX5PRKDCPARP14DNPH1TNKS | |
| SCHEMBL15959675 | 0.86 | ALOX5 (0.49) | ALOX5PRKDCPARP14DNPH1TNKS | |
| SCHEMBL15959758 | 0.86 | ALOX5 (0.49) | ALOX5PRKDCPARP14DNPH1TNKS | |
| SCHEMBL15959692 | 0.86 | ALOX5 (0.49) | ALOX5PRKDCPARP14DNPH1TNKS | |
| SCHEMBL17248427 | 0.85 | ALOX5 (0.51) | ALOX5PRKDCPARP14TNKSTNKS2 | |
| SCHEMBL26512506 | 0.85 | ALOX5 (0.46) | ALOX5PRKDCPARP14PIK3CDBRD4 | |
| SCHEMBL16133239 | 0.84 | ALOX5 (0.62) | ALOX5PRKDCPARP14DNPH1TNKS | |
| SCHEMBL16133229 | 0.84 | ALOX5 (0.62) | ALOX5PRKDCPARP14DNPH1TNKS | |
| SCHEMBL26512734 | 0.84 | ALOX5 (0.46) | ALOX5PRKDCPARP14TNKSTNKS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160204345-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2016-07-14 | — | — | US | disclosed |
| US-20160204345-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2016-07-14 | — | — | US | disclosed |
| US-9166177-B2 | Ditriphenylene derivative and organic electroluminescent device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2015-10-20 | — | — | US | disclosed |
| US-9166177-B2 | Ditriphenylene derivative and organic electroluminescent device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2015-10-20 | — | — | US | disclosed |
| US-20140231754-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Yen, Feng-wen (TW) | 2014-08-21 | — | — | US | disclosed |
| US-20140231754-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Yen, Feng-wen (TW) | 2014-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160204345-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | NR2E1, NR0B1, NR2E3 | ALOX5 1110/4885PRKDC 4688/4885PARP14 1581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.